Top Gum Industries Ltd. TPGM

Gummy supplements specialist TopGum Industries, Ltd. (TASE: TPGM), unveils a new collection of gummies addressing two leading themes in the longevity category. The line includes five functional gummy compositions designed to support cognition and eye health.

TopGum Industries Ltd. (TASE: TPGM), a leading developer and manufacturer of gummy dietary supplements, today announced that, based on year-to-date performance and updated forecasts, it expects revenue in the second half of 2026 to reflect an annualized run rate of more than $145 million.

TopGum Industries Ltd. (TASE: TPGM), the leading company in the gummy-format dietary supplements market, published its financial results for the first quarter of 2026 and reports another record quarter. The Group's revenues amounted to approximately $31.9 million - an all-time high - representing an increase of about 85% compared to the first quarter of 2025, driven by a triple-digit surge of 162% in the dietary supplements segment. These results were achieved despite the war with Iran and the t

TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The transaction, first announced via a binding letter of intent on January 20, 2026, deepens TopGum's presence in the United States, its largest target market, and positions TopGum a

Gummy supplement innovator TopGum Industries, Ltd. (TASE: TPGM) unveils its new line of gummy infusions designed specifically for women. The collection of seven formulations caters to the evolving needs of women throughout every phase of life, from teens to menopause and beyond. The wellness treats will be on display at Vitafoods Europe 2026 in Barcelona, booth #3G88.

TopGum Industries Ltd. (TASE: TPGM), the leading company in the dietary supplements gummy dosage-form market, announced today that it has signed a Binding Letter of Intent (LOI) to acquire U.S. operations engaged in the manufacture of pharmaceutical products and dietary supplements in gummy dosage form.